Sleep Medicine Research
DOSA Trial
Randomized Control Trial of Oxygen Therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea
CHILD'S AGE: 5 – 17.9 years old
CHILD'S SEX AT BIRTH: All
HEALTHY PARTICIPANTS: No
CHILD'S SEX AT BIRTH: All
HEALTHY PARTICIPANTS: No
TYPE: Interventional Study
CONDITION: Obstructive Sleep Apnea (OSA) and Down Syndrome
CONDITION: Obstructive Sleep Apnea (OSA) and Down Syndrome
LOCATION: University Hospitals Cleveland Medical Center
Learn More About This Research Study
For more information, please contact study coordinator, Emily Witte, at 216-260-9697 or complete the online form below.
Study Purpose
The purpose of this study is to assess whether oxygen supplementation during sleep improves cognitive functioning such as working memory among children who have Down syndrome with moderate to severe obstructive sleep apnea (OSA).
Who Can Participate
Participants 5-17.9 years of age with Down syndrome and diagnosed with OSA after having the typical surgery for OSA in children (adenotonsillectomy) may be eligible for this study.
For more information about this trial visit Dosatrial.
